Clinical Research Designs
|
Paper details
PART 1: (20 points) Define the following: Predictor variable PART 2: (50 points) Sample size calculations: The research question is whether there is a difference in the efficacy of Study drug A and Study drug B (which is the standard of care) for the treatment of type 2 diabetes. The investigator has planned a quadruple blind randomized clinical trial to study whether the study drug A is effective in reducing glycosylated hemoglobin (HbA1c) as compared to study drug B (standard of care ) in participants with Type 2 Diabetes after 12 weeks. A previous study has reported the mean HbA1C level in subjects treated for diabetes is 8 % (% here is a unit of measure) with a standard deviation of 2% (% here is a unit of measure). The investigator would like to be able to detect a difference of 20% or more in the mean HbA1C levels between the two groups Please note: HbA1c is measured and expressed in percentage as units and not as a percentage of proportions. Use a two-sided ⍺ = 0.05 And power 0.80. Calculate the sample size (Answer points 1 – 6) Hint: Use appropriate table (6A, 6B or 6C depending on the test you select) from the textbook. Now, considering a 10% dropout rate what would be the increased sample size. (Answer point 7) State in details: The null hypothesis (5 points) PART 3: (30 points) Using the Clinical Trial Workbook, 2nd edition – review the SWP Pharmaceutical protocol. Is(are) the statistical test(s) used correct. Yes or no and justify. Assume that the sample size provided in the protocol is a fixed sample size. Work backward and calculate the detectable effect size. If you need power for your calculations use the power of 80%. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Preferred language style US English |






